Pioneering Global Collaboration
Dianne Trauring and Nancy Carpenter lost their mother in 2010 after a long battle with Alzheimer’s disease. Stories like theirs drive Indiana University School of Medicine researchers to further advance global collaboration of dementia research in order to prevent and effectively treat Alzheimer’s disease.
An estimated 5.5 million people in the U.S. suffer from Alzheimer’s disease or related dementias. To better understand and end the suffering related to this devastating disease, IU School of Medicine’s accomplished team of experts understands that collaboration is key. These internationally recognized and award-winning physician scientists are pioneering global collaboration of multidisciplinary dementia research to study the fundamental causes and treatment options with the hopes of solving Alzheimer’s disease and related dementias.
National Leader in Alzheimer’s Research
At the forefront of Alzheimer research for almost 30 years, IU School of Medicine established the Indiana Alzheimer Disease Center (IADC), one of only 32 centers in the United States solely committed to Alzheimer’s research. Most Alzheimer investigators and programs at IU School of Medicine are affiliated with Indiana Alzheimer Disease Center, where resources are shared to support and facilitate research advancements. This center attracts world-class faculty who use advanced technology to lead some of the most robust dementia research in the world in order to achieve the national plan to address Alzheimer’s disease.
Recruiting Healthy and Affected Participants for Clinical Trials
Successful clinical trials rely on both healthy individuals and people with Alzheimer’s disease to identify symptoms and gene markers that indicate the disease. IU School of Medicine has many active clinical trials. Information on these studies, including who’s needed to help advance these research studies, is available.
Accomplished Faculty Investigators
Advanced technology driving patient-centered research
Indiana University School of Medicine is training the next generation of researchers specifically focused on discovering new ways to increase understanding, diagnosis and treatment of Alzheimer’s disease and other dementias. Outstanding researchers have opportunities here to gain experience working on multidisciplinary studies that involve local, national and international collaborators. Research studies range from genetics and medical neuroscience to medical and molecular genetics and computer science/bioinformatics–and beyond.